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Main Summary: 
Whole genome sequencing should replace current molecular typing used routinely in clinical 
microbiology laboratories. Patient-to-patient spread of M. abscessus is not common. 
Environmental screening may provide a better understanding of acquisition of M. abscessus 
infections.  
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Abstract 
Background: 
Mycobacterium abscessus is an extensively drug resistant pathogen that causes pulmonary 
disease particularly in cystic fibrosis (CF) patients. Identifying direct patient-to-patient 
transmission of M. abscessus is critically important in directing infection control policy for 
the management of risk in CF patients. A variety of clinical labs have used molecular 
epidemiology to investigate transmission. However there is still conflicting evidence as to 
how M. abscessus is acquired and whether cross-transmission occurs. Recently labs have 
applied whole-genome sequencing (WGS) to investigate this further and in this study we 
investigate whether WGS can reliably identify cross-transmission in M. abscessus. 
Methods: 
We retrospectively sequenced the whole genomes of 145 M. abscessus isolates from 62 
patients seen at four hospitals in two countries over 16 years. 
Results: 
We have shown that a comparison of a fixed number of core single nucleotide variants 
(SNVs) alone cannot be used to infer cross-transmission in M. abscessus but does provide 
enough information to replace multiple existing molecular assays. We detected one episode of 
possible direct patient-to-patient transmission in a sibling pair. We found that patients 
acquired unique M. abscessus strains even after spending considerable time on the same 
wards with other M. abscessus positive patients.  
Conclusions: 
This novel analysis has demonstrated that the majority of patients in this study have not 
acquired M. abscessus through direct patient-patient transmission or a common reservoir. 
Tracking transmission using WGS will only realise its full potential with proper 
environmental screening as well as patient sampling. 
Keywords: Nontuberculous mycobacteria, whole-genome sequencing, transmission, cystic 
fibrosis, phylogenomics  
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Background 
Mycobacterium abscessus (recently renamed as Mycobacteroides abscessus) [1], is a group 
of three closely related subspecies M. abscessus subsp. abscessus, M. abscessus subsp. 
massiliense and M. abscessus subsp. bolletii [1,2]. These rapidly-growing, non-tuberculous 
mycobacteria cause chronic pulmonary disease, particularly in patients with cystic fibrosis 
(CF) and other chronic lung diseases. M. abscessus is an important pathogen that has 
emerged in the CF patient population and that has been associated with poor clinical 
outcomes, especially following lung transplantation [3–5]. This is due, at least in part, to the 
extensive antibiotic resistance that makes infections with this organism difficult to treat [2,6]. 
CF patients infected with M. abscessus are frequently not listed for transplant, therefore the 
acquisition of this pathogen is considered to be a serious complication in this group.  
 
The epidemiology of M. abscessus strains has been studied using Variable Nucleotide 
Tandem Repeats (VNTR) and Multi Locus Sequence Typing (MLST) [7]⁠. The clustering of 
globally spread sequence types was confirmed with whole genome sequencing (WGS) and 
has provided greater resolution in how the various lineages are related as well as predicting 
possible transmission routes [8,9]. A dominant method of transmission of M. abscessus 
remains contested [10,11], with evidence for and against patient-to-patient transmission being 
the common route [8,12–14]⁠⁠. M. abscessus is ubiquitous in the environment with its niche 
hypothesised to be free-living amoeba [15,16], but due to the difficulties in isolating the 
organism, little has been done to track environment-to-patient acquisition. Confirmation of 
direct patient-to-patient transmission is important as it influences management of high-risk 
patients and it could increase the effectiveness of infection control interventions by directing 
the use of limited resources. 
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In this retrospective study we assessed utility of using WGS to characterise subspecies, 
antimicrobial resistance (AMR) profiles and typing of M. abscessus isolates.  We also wanted 
to utilise the data to investigate the scale of patient-to-patient transmission and whether 
identification of single nucleotide variants (SNVs) by WGS can confirm transmission. To do 
this we have sequenced the genomes of 145 M. abscessus clinical isolates from a well 
characterised cohort of 62 patients from four hospitals in two countries over 16 years.  
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Methods 
Patients and Samples collection 
We collected 33 M. abscessus isolates from 30 patients at Hospital de la Santa Creu I Sant 
Pau (bcn_hsp), Hospital Clínic (bcn_hcl) and Hospital Vall d’Hebron (bcn_hvh), Barcelona, 
Spain and 112 isolates from 32 patients from Great Ormond Street Hospital (GOSH), 
London, UK (Table 1). At GOSH, CF patients were screened for non-tuberculous 
mycobacterial (NTM) infection when attending clinics as part of their routine management. 
In addition to this, CF and other patients at all hospitals included in this study were screened 
for NTM infection when they presented with suggestive clinical symptoms or exacerbations. 
Demographic and patient location data were obtained from the patient administration system 
and microbiological data from the laboratory information management system using 
Structured Query Language (SQL) and Excel spreadsheets. Additional sources of information 
included CF and transplant databases. American Thoracic Society consensus guidelines were 
used to verify evidence of non-tubercuolous mycobacterial infection [17]⁠. All 
investigations were performed in accordance with the Hospitals Research governance policies 
and procedures. 
 
DNA extraction, Whole-Genome Sequencing and Multi Locus Sequence Typing (MLST) 
Information on DNA extraction, whole-genome sequencing and MLST are included in 
Supplementary Methods. 
 
Read mapping and variant calling 
Sequenced reads for all samples were first mapped to M. abscessus subsp. abscessus ATCC 
19977 using BBMap v37.90 (Joint Genome Institute). Single nucleotide variants (SNVs) 
were called against the reference genome using freebayes v1.2.0 [19] and variants were 
filtered to only include those at sites with a mapping quality >30, a base quality >30, at least 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciz526/5521616 by Institute of C
hild H
ealth/U
niversity C
ollege London user on 01 July 2019
  
five supporting reads, where the variant was present on at least two forward and reverse 
strand reads and  present at the 5’ and 3’ end of at least two  reads.  
 
Phylogenetic analysis 
Potential regions of recombination were identified from the consensus genome sequences 
using Gubbins v2.3.1 [20]. Regions within the genome with low coverage (< 5x) were 
masked on a per sample basis and regions with low coverage across 75% of samples were 
masked across the entire dataset. A maximum likelihood tree was inferred from all samples 
using RAxML v8.2.4 [21]⁠ using a GTRCAT model with 99 bootstraps. Sub-species were 
identified for each sample based on their position upon this tree. 
 
Separate sub-trees were also inferred for M. abscessus subsp. massilense sequences, as well 
as for M. abscessus subsp. abscessus ST-1 and ST-26 sequences. All samples in each sub-tree 
were mapped against a suitable reference. M. abscessus subsp. massilense str. GO 06 was 
used as the reference sequencing for study massilense sequences and the de novo assembly of 
the earliest ST-26 study sequence (ldn_gos_2_520) was used as a reference for other ST-26 
samples. M. abscessus subsp. abscessus ATCC 19977 was again used as the reference for ST-
1 sequences as it is the same sequence type. All sub-trees were generated using the same 
method outlined above, apart from ST-26 subtree, which did not use Gubbins but instead 
variants were filtered if 3 SNVs were found within a 100bp window.  
 
Sequence clusters 
Sequence clusters to infer possible transmission were generated using three different methods 
on each subtree. First we used a SNV threshold that was based on the upper bounds of all 
within patient diversity applied to complete linkage hierarchical clustering based on pairwise 
SNV matrix. Secondly we assigned clusters using the R package rPinecone as it incorporates 
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SNV thresholds and root-to-tip distances and so has been useful when applied to clonal 
populations [22]. Lastly we also used hierBAPS [23] to assign clusters, however due to the 
fact that all samples are included in the sequence clusters we found it was not appropriate for 
this study question. We made the assumption that any strains taken from different patients 
that were within sequence cluster constituted a possible transmission event. 
 
De novo assembly 
All samples underwent de novo assembly of bacterial genomes using SPAdes and pilon 
wrapped in the Unicycler v0.4.4 package [24]. Assembled contigs were annotated using 
prokka v1.13 [25] and comparison of the accessory genome was generated using roary 
v3.12.0 [26]. To generate a list of genes that could be used to differentiate isolates we filtered 
the annotated genes to remove coding sequences (CDS) greater than 8000 bp and less than 
250 bp, as well as those only present in a single sample and those present in every sample.  
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Results 
M. abscessus population distribution 
We obtained whole genome sequences for 145 M. abscessus isolates from 62 patients. Thirty-
three M. abscessus from Barcelona subdivided into 24 M. abscessus subsp. abscessus, two M. 
abscessus subsp. bolletii and seven M. abscessus subsp. massiliense. A hundred and twelve 
M. abscessus from UK subdivided into 78 M. abscessus subsp. abscessus, one M. abscessus 
subsp. bolletii and 33 M. abscessus subsp. massiliense. Sample MLST definitions, VNTR and 
AMR associated mutations are shown in supplementary table 1.  
 
Possible transmission within M. abscessus clusters 
To confirm possible transmission between patients we required their isolate genomes to be 
clustered together by two independent methods and epidemiological evidence that both 
patients were at the same hospital during the same time period. Using WGS data we inferred 
a phylogenetic tree from reference genome SNV matrix for all patients (Figure 1).  We 
observed two low variant clusters of isolates that corresponded to ST-1 and ST-26 Pasteur 
MLST profiles (VNTR II and I respectively), as well as other closely related M. abscessus 
subsp. massilense isolates between patients. We used a SNV matrix from mapping against a 
reference (M. abscessus subsp. abscessus ATCC19977), as well as hierBAPS and rPinecone 
to predict sequence clusters. The sequence clusters generated from the single reference SNV 
matrix provided no further information than the MLST profiles, and in many cases provided 
spurious findings with large groups of isolates clustered with no epidemiological link 
(Supplementary Figure 1). This included large sequence clusters relating to a single MLST 
type which included isolates from different hospitals and countries.  
Mapping to a single reference genome led to the inability of a single SNV cut-off, or model, 
to exclude unrelated isolates from sequence clusters because the number of pairwise SNV 
distances varied greatly between both subspecies and specific lineages (Figure 2). For 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciz526/5521616 by Institute of C
hild H
ealth/U
niversity C
ollege London user on 01 July 2019
  
example, the pairwise median (interquartile range) SNV distance between just ST-1 isolates 
was 73 (62 – 81) compared to 29589 (27701 – 63703) for all M. abscessus subsp. abscessus 
isolates. The same differences were seen in M. abscessus subsp. massilense as well with a 
pairwise median (IQR) SNV distance between ST-23 and ST-48 isolates of 2084 (960 – 
7274) compared to 70545 (59947 – 71891) across all isolates from the subspecies. 
 
Sub-tree sequence clusters 
The variation in the scale of diversity within subspecies and sequence type hampered efforts 
to capture possible transmission events. In order to improve accuracy of sequence clustering, 
multiple sub-trees were made for closely related isolates using a more suitable reference 
sequence. We separated M. abscessus subsp. abscessus and M. abscessus subsp. massilense 
isolates, as well as further sub-trees for ST-1 (VNTR II), ST-26 (VNTR I) and ST-23/ST-48 
(VNTR III) isolates. We also integrated the presence of accessory genes when interrogating 
possible sequence clusters for transmission (Figures 3, 4 & 5). Sequence clusters were 
assigned for each sub-tree using both a single SNV threshold (Supplementary Figure 2) and 
rPinecone. Overall we found that predicting transmission from the sub-trees reduced the 
number of different patients clustered together from 46 to 19 and the number of possible 
sequence clusters suggesting patient-to-patient transmission from 11 to seven. 
A total of 18 sequence clusters (I – XVIII) were identified (listed in supplementary table 1), 
15 of these were within the sub-trees (I – XV), and seven clusters contained samples from 
more than one patient (IV, V, VI, VIII, XIV, XVI & XVII). We found no sequence clusters 
that contained samples from both the UK and Spain. We found no evidence of transmission 
between patients within ST-26. (Figure 3). Within ST-1, four clusters (IV, V, VI and VIII) 
containing samples from more than one patient were found. Three of these clusters (IV, V and 
VI) contained isolates from nine patients from multiple hospitals within Barcelona. Only two 
of these patients were in hospital during the same time period (cluster VI: bcn_hcl_009 and 
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bcn_hvh_30), but both were treated in different hospitals. Cluster VIII suggested transmission 
between two patients (ldn_gos_18 and ldn_gos_19) who were siblings with previously 
assumed either direct transmission or common reservoir (Figure 4) [13]. A single cluster 
(XIV) containing samples from two patients (ldn_gos_46 and ldn_gos_7) was found among 
ST-23 isolates. However, the two strains were isolated from samples taken nine years apart 
(Figure 5). Patient ldn_gos_7 was already positive for M. abscessus on first admission to 
Great Ormond Street Hospital (GOSH), and the two patients were present at the lung function 
lab within a month of each other on two occasions, but never in the same location at the same 
day, and never admitted to the same ward. 
All samples found within their respective clusters also contained similar accessory gene 
profiles with the median (IQR) shared percentage of accessory genes within a sequence 
cluster being 89% (79% – 94%) compared to 18% (12% - 37%) for isolates not in the same 
sequence cluster.  
For the 32 GOSH CF patients included in the study, 16 became infected with M. abscessus 
after their first visit to clinic (Table 1), however transmission confirmed by both WGS and 
epidemiological data could only be identified in one case (gos_19) thus suggesting a different 
route of acquisition for the rest of these patients. 
 
Discussion 
This study has shown that whole genome sequencing of M. abscessus isolates can determine 
sub-species, identify previously reported AMR associated mutations and provide common 
typing definitions in a single workflow. This single method can replace the multiple existing 
molecular assays used in clinical microbiology laboratories to provide the same information 
and could be used to predict novel resistance variants [27]. We used the WGS data to 
investigate the likelihood of cross-transmission and found 43 (69%) patients had unique 
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isolates that did not cluster with other patients. We identified seven sequence clusters from 
the remaining 19 patients but only one pair of patients (ldn_gos_18 and ldn_gos_19) had a 
plausible epidemiological link to support possible patient-to-patient transmission, as they 
were siblings. All other patients with genetically similar strains were either isolated in 
different countries, different hospitals or isolated from samples that were taken years apart, 
making direct transmission of these strains extremely unlikely. 
Every M. abscessus isolated from a GOSH patient was sequenced and so the dataset 
generated represents a complete picture of M. abscessus infection in this hospital, which is 
vital for inferring transmission. Most of these patients were only attending clinics at GOSH, 
therefore this study has captured all of their M. abscessus isolates and they are unlikely to 
have been in contact with M. abscessus positive patients at other hospitals (Table 1). 
Therefore, if direct patient-patient transmission was occurring frequently we would expect to 
see evidence of it here. In contrast to this we found that the majority of patients in this study 
had unique strains and the majority of sequence clusters were multiple isolates from the same 
patients. This study confirms previous findings that despite many M. abscessus negative 
patients spending considerable time on the same wards as patients with ongoing M. abscessus 
infections they did not subsequently acquire genetically similar isolates [13,14,28].  
We have therefore found that a fixed number of SNVs cannot be reliably used to infer cross-
transmission across all M. abscessus isolates as there seems to be irreconcilable differences in 
the substitution rate between both sub-species and dominant clones. These difficulties are 
similar to those seen in Legionella pneumophila outbreaks where the majority of cases can 
belong to only a few sequence types [26]. L. pneumophila can also display different scales of 
genetic diversity within different sequence or genotypes and so it is also recognised that a 
single SNV threshold cut-off will not provide sufficient discriminatory power [27]. When 
using WGS to infer relatedness in M. abscessus there has previously been an attempt to find 
an absolute threshold which can rule in or rule out strains into a transmission event. This has 
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previously been placed as below 25-30 SNVs [8,14,29,30]⁠. From our findings we would 
advocate using a suitable genetically similar reference sequence when carrying out core 
genome SNV calling, especially for the dominant clones such as ST-1 and ST-26. There is a 
large amount of variation within the genomes of M. abscessus [31] and so the use of a single 
reference such as M. abscessus subsp. abscessus ATCC 19977 will mask many differences 
between strains and generate spurious clusters of genetically similar sequences. Where a 
suitable reference is not available we recommend using a high quality draft de-novo assembly 
of the first isolated sample to compare other isolates against as in the example of the ST-26 
samples in this study (Figure 3).  
In addition to core genome SNV analysis we have also found the integration of accessory 
genome information is a useful indicator of relatedness within M. abscessus isolates that can 
be used to further interrogate assigned sequence clusters. Generally there was good 
concordance between the proportion of putative genes shared and the SNV distance between 
two samples. This is helped by using a closely related reference sequences to map sequence 
reads against. We have seen in this study, and previously [32], diversity in the accessory 
genome profiles as well as in the number of SNPs and AMR associated mutations taken from 
multiple samples from the same patient on the same day. However we have always found 
inter-patient diversity to be greater than that seen within the same patient. This would suggest 
that any direct transmission between patients of even minority populations would still be 
identified by WGS and, taken together, the data suggests that person-to-person transmission 
of M. abscessus in paediatric patients in our institution is very uncommon. In this study we 
have an example of two patients with transmission predicted by genomic epidemiology 
(ldn_gos_7 and ldn_gos_46) that had attended a lung function laboratory on three occasions 
within a month of each other. In this case, the only way transmission could have occurred is if 
ldn_gos_7 who was already infected contaminated the environment and this then transmitted 
to ldn_gos_46. The predominant view [8] that human-to-human transmission occurs via 
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contamination of fomites by respiratory secretions could explain this, although no other 
instances of this appeared to have occurred, despite numerous other CF patients attending the 
unit over many years. What is harder to explain is that for this to be the case, the interval 
between exposure and culture positivity was nine years. It could be that M. abscessus remains 
present but undetectable by conventional methods for this time period, or intriguingly could 
cause latent infection, like what occurs with Mycobacterium tuberculosis. To the best of our 
knowledge, this has never been a demonstrated part of the pathogenesis of M. abscessus 
infection, and maybe worthy of further investigation. 
In agreement with previous studies we have found an international distribution of M. 
abscessus dominant clones [8]. We have found WGS to be useful to confirm whether 
different patient’s strains are unrelated, even within the dominant clones, but it has been far 
more difficult to reach definite conclusions about cross-transmission. Without environmental 
samples we cannot rule out the possibility of intermediate sources of infection and so WGS 
as a tool for tracking cross-transmission in M. abscessus will only realise its full potential 
with proper screening of environmental sources alongside longitudinal patient sampling. 
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Table 1: Study patient information. 
Patient Hospital Subspecies Sex Underlying condition Source of isolate Infection status 
at first contact 
Date of first 
isolate 
Date of first 
contact 
Date of first 
ward 
admission 
bcn_hcl_002 HCL abscessus M Cystic Fibrosis Lung Already Infected 30/12/13 30/12/13 30/12/13 
bcn_hcl_004 HCL abscessus F Bronchiectasis Lung Not infected 09/05/13 01/01/12 01/01/12 
bcn_hcl_005 HCL abscessus F None Lung Already Infected 01/08/14 01/08/14 01/08/14 
bcn_hcl_007 HCL abscessus M Liver Neoplasi Blood Not infected 10/09/14 2013 2013 
bcn_hcl_008 HCL massilense M None Lung Already Infected 30/06/14 30/06/14 30/06/14 
bcn_hcl_009 HCL abscessus F Bronchiectasis Lung Not infected 08/05/13 2008 2008 
bcn_hsp_011 HSP bolletii M None Lung Already Infected 01/12/00   
bcn_hsp_012 HSP abscessus F None Lung Already Infected 31/10/08 31/10/08 31/10/08 
bcn_hsp_014 HSP abscessus F None Lung Already Infected 30/01/01 30/01/01 30/01/01 
bcn_hsp_019 HSP abscessus M None Lung Already Infected 23/01/14 03/12/04 23/01/14 
bcn_hsp_021 HSP abscessus F Chronic bronchial infection Lung Not infected 24/04/15 02/02/14 02/02/14 
bcn_hsp_1 HSP abscessus F None Lung Already Infected 17/09/09 17/09/09 17/09/09 
bcn_hsp_2 HSP abscessus F None Lung Already Infected 24/03/09 24/03/09 24/03/09 
bcn_hsp_3 HSP abscessus F None Lung Already Infected 05/06/07 05/06/07 05/06/07 
bcn_hvh_030 HVH abscessus F Cystic Fibrosis Lung  09/01/12   
bcn_hvh_031 HVH abscessus F Cystic Fibrosis Lung  06/05/09   
bcn_hvh_033 HVH abscessus M Cystic Fibrosis Lung  15/07/13   
bcn_hvh_034 HVH massilense F Cystic Fibrosis Lung  23/01/09   
bcn_hvh_035 HVH abscessus F Cystic Fibrosis Lung  14/02/14   
bcn_hvh_036 HVH massilense M Cystic Fibrosis Lung  29/03/11   
bcn_hvh_037 HVH abscessus F Cystic Fibrosis Lung  30/01/13   
bcn_hvh_038 HVH abscessus F Cystic Fibrosis Lung  25/07/14   
bcn_hvh_039 HVH abscessus M Cystic Fibrosis Lung  22/01/07   
bcn_hvh_040 HVH massilense M Cystic Fibrosis Lung  04/09/09   
bcn_hvh_041 HVH bolletii F Lung transplant Lung  29/08/12   
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bcn_hvh_042 HVH massilense F Lung transplant Lung  18/04/12   
bcn_hvh_043 HVH abscessus M Lung transplant Lung  23/02/13   
bcn_hvh_045 HVH massilense M Lung transplant Lung  10/04/13   
bcn_hvh_046 HVH massilense M Lung transplant Lung  08/11/13   
bcn_hvh_047 HVH abscessus F Lung transplant Lung  28/03/13   
ldn_gos_1 GOSH bolletii F Cystic Fibrosis Lung Already Infected 29/06/2004 27/06/2004 27/06/2004 
ldn_gos_11 GOSH massilense F Cystic Fibrosis Lung Not infected 07/10/2008 09/06/1997 15/09/1998 
ldn_gos_14 GOSH massilense F Cystic Fibrosis Lung Already Infected 25/04/2005 24/04/2005 24/04/2005 
ldn_gos_15 GOSH abscessus F Cystic Fibrosis Lung Not infected 26/06/2006 29/08/1995 26/05/2003 
ldn_gos_17 GOSH abscessus M Cystic Fibrosis Lung Not infected 21/04/2009 04/07/1995 01/01/1997 
ldn_gos_18 GOSH abscessus M Cystic Fibrosis Lung Not infected 13/12/2004 27/02/2001 03/07/2002 
ldn_gos_19 GOSH abscessus F Cystic Fibrosis Lung Not infected 18/06/2007 16/04/1991 27/07/1994 
ldn_gos_2 GOSH abscessus F Cystic Fibrosis Lung Already Infected 18/08/2005 15/08/2005 15/08/2005 
ldn_gos_21 GOSH abscessus M Cystic Fibrosis Lung Not infected 28/10/2008 11/11/1996 20/10/1997 
ldn_gos_22 GOSH abscessus F Cystic Fibrosis Lung Not infected 08/05/2008 15/02/1994 05/01/1998 
ldn_gos_23 GOSH massilense F Cystic Fibrosis Lung Not infected 03/02/2009 17/06/2003 10/11/2006 
ldn_gos_24 GOSH abscessus F Cystic Fibrosis Lung Already Infected 30/03/2009 30/03/2009 30/03/2009 
ldn_gos_27 GOSH abscessus F Cystic Fibrosis Lung Not infected 16/10/2010 07/05/2003 07/05/2003 
ldn_gos_28 GOSH massilense F Cystic Fibrosis Lung Already Infected 06/06/2011 06/06/2011 06/06/2011 
ldn_gos_3 GOSH abscessus F Cystic Fibrosis Lung Already Infected 05/09/2005 04/09/2005 04/09/2005 
ldn_gos_30 GOSH abscessus F Cystic Fibrosis Lung Not infected 28/06/2012 11/11/1997 13/01/1999 
ldn_gos_32 GOSH abscessus F Cystic Fibrosis Lung Already Infected 08/11/2010 08/11/2010 08/11/2010 
ldn_gos_35 GOSH abscessus F Cystic Fibrosis Lung Not infected 21/10/2013 05/08/2000 05/08/2000 
ldn_gos_36 GOSH abscessus F CNS Tumour Faeces Not infected 11/01/2014 10/10/2013 N/A 
ldn_gos_37 GOSH abscessus M Cystic Fibrosis Lung Not infected 20/02/2014 01/10/2013 28/10/2013 
ldn_gos_38 GOSH massilense M Cystic Fibrosis Lung Already Infected 31/07/2014 28/04/2014 28/04/2014 
ldn_gos_39 GOSH massilense F Cystic Fibrosis Lung Already Infected 29/09/2014 29/09/2014 29/09/2014 
ldn_gos_40 GOSH abscessus F Cystic Fibrosis Lung Already Infected 29/03/2015 16/02/2015 16/02/2015 
ldn_gos_41 GOSH abscessus M Cystic Fibrosis Lung Already Infected 02/06/2015 01/06/2015 01/06/2015 
ldn_gos_42 GOSH abscessus M SCID Lung Not infected 30/07/2015 27/09/2002  
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciz526/5521616 by Institute of C
hild H
ealth/U
niversity C
ollege London user on 01 July 2019
  
ldn_gos_43 GOSH abscessus M Cystic Fibrosis Lung Not infected 03/08/2015 02/11/1999 25/02/2001 
ldn_gos_44 GOSH massilense F Cystic Fibrosis Lung Already Infected 27/10/2015 26/10/2015 26/10/2015 
ldn_gos_45 GOSH abscessus M Cystic Fibrosis Lung Already Infected 26/02/2016 05/01/2015 05/01/2015 
ldn_gos_46 GOSH massilense F Cystic Fibrosis Lung Not infected 09/01/2017 10/11/2004 10/11/2004 
ldn_gos_7 GOSH massilense F Cystic Fibrosis Lung Already Infected 17/12/2007 17/12/2007 17/12/2007 
ldn_gos_8 GOSH abscessus M Cystic Fibrosis Lung Not infected 29/06/2007 17/06/1997 17/06/1998 
ldn_gos_9 GOSH abscessus F Cystic Fibrosis Lung Not infected 04/12/2007 20/08/2007 10/06/2008 
 
Abbreviations: HCL, Hospital Clínic; HSP, Hospital de la Santa Creu I Sant Pau; HVH, Hospital Vall d’Hebron; GOSH, Great Ormond Street Hospital   
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Figure legends 
 
Figure 1. Maximum likelihood single nucleotide variant (SNV) tree using only the 
earliest isolated sample from all 62 patients. SNVs were identified from mapping reads to 
ATCC19977 M. abscessus subsp. abscessus reference genome. Sample names are highlighted 
in colour based on what hospital they were isolated from: Great Ormond Street Hospital, 
London, UK, Hospital Clínic, Barcelona, Spain, Hospital de la Santa Creu i Sant Pau, 
Barcelona, Spain, and Hospital Vall d’Hebron, Barcelona, Spain. The scale bar represents the 
number of single nucleotide variants and node bootstrap scores below are shown if below 75.  
 
Figure 2. Frequency of pairwise single nucleotide variant (SNV) distances between all 
isolates. SNVs were identified from mapping sequence reads to M. abscessus subsp. 
abscessus ATCC19977. The full plot includes all samples while the bottom subsidiary plot 
only includes isolates that have a pairwise difference between zero and 1000 SNVs. 
 
Figure 3. Maximum likelihood single nucleotide variant (SNV) tree for all ST-26 
isolates. SNVs were identified from mapping reads to a de-novo assembled study isolate 
genome (ldn_gos_2_520). Samples are highlighted based on inclusion in sequence clusters. 
The tree is annotated with the presence (black) and absence (white) of accessory genes as 
well as the presence of AMR associated genes and mutations. This included presence of a 
functional erm(41) gene conferring inducible resistance to macrolides, presence of two rrl 
mutations conferring high level macrolide resistance and the presence of mutation in rrs 
conferring high level amikacin resistance. The scale bar represents the number of single 
nucleotide variants and node bootstrap scores below are shown if below 75. 
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Figure 4. Maximum likelihood single nucleotide variant (SNV) tree for all ST-1 isolates. 
SNVs were identified from mapping reads to M. abscessus subsp. abscessus ATCC19977. 
Samples are highlighted based on inclusion in sequence clusters. The tree is annotated with 
the presence (black) and absence (white) of accessory genes as well as the presence of AMR 
associated genes and mutations. This included presence of a functional erm(41) gene 
conferring inducible resistance to macrolides, presence of two rrl mutations conferring high 
level macrolide resistance and the presence of mutation in rrs conferring high level amikacin 
resistance. The scale bar represents the number of single nucleotide variants and node 
bootstrap scores below are shown if below 75. 
 
Figure 5. Maximum likelihood single nucleotide variant (SNV) tree for all ST-23 and 
ST-48 isolates. SNVs were identified from mapping reads to M. abscessus subsp. massilense 
GO 06. Samples are highlighted based on inclusion in sequence clusters. The tree is 
annotated with the presence (black) and absence (white) of accessory genes as well as the 
presence of AMR associated genes and mutations. This included presence of a functional 
erm(41) gene conferring inducible resistance to macrolides, presence of two rrl mutations 
conferring high level macrolide resistance and the presence of mutation in rrs conferring high 
level amikacin resistance. The scale bar represents the number of single nucleotide variants 
and node bootstrap scores below are shown if below 75. 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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